Want to join the conversation?
Leading specialty pharmaceutical company, $PRGO today received an AB therapeutic equivalent rating & USFDA approval for BenzaClin, a topical gel treatment for acne vulgaris. Both generic & branded sales generated $231MM in revenue last year."This product approval & launch is an important addition to $PRGO's growing Rx portfolio," said Joseph, CEO.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!
$SGY is expected to achieve $6.17 price target in next year, with a minimum target of $3.00, due to the price increase of 27.85% to $6.29 during the last trading session.
$SWHC showing consistent increase in sales for the past three quarters suggesting the US craze for firearms is not going to subside soon.